Codes / ICD10CM / L64.0

L64.0 Drug-induced androgenic alopecia

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Drug-induced androgenic alopecia

Summary

Drug-induced androgenic alopecia is a condition characterized by hair loss resulting from the effects of certain medications. It typically presents as a patterned loss of hair, similar to androgenetic alopecia, but is directly linked to drug exposure. The condition may be reversible if the causative medication is discontinued, though recovery depends on the duration and extent of hair follicle damage.

Causes

This condition is caused by medications that disrupt the hair growth cycle or increase androgenic activity, leading to hair follicle miniaturization. Common culprits include anabolic steroids, certain hormonal therapies, and drugs that alter androgen metabolism. The mechanism involves either direct toxicity to hair follicles or indirect effects on hormonal pathways that regulate hair growth.

Risk Factors

  • Use of anabolic steroids or androgenic medications
  • Exposure to drugs that alter hormonal balance (e.g., some contraceptives, hormone replacement therapies)
  • Prolonged use of medications known to affect hair growth
  • Genetic predisposition to androgenetic alopecia may increase susceptibility

Symptoms

  • Gradual, patterned hair loss, often starting at the crown or temples
  • Thinning of hair shafts, leading to reduced hair density
  • Possible increased hair shedding during the early stages of medication use
  • No associated scalp inflammation or scarring in most cases

Diagnosis

Diagnosis is based on a thorough medical history, including medication use, and a physical examination of the scalp and hair pattern. A healthcare provider may assess the distribution of hair loss and rule out other causes, such as nutritional deficiencies or thyroid disorders. In some cases, a scalp biopsy may be performed to evaluate hair follicle health, though this is not always necessary.

Treatment Options

  • Discontinuation of the causative drug: If feasible, stopping the medication may allow hair regrowth.
  • Topical treatments: Minoxidil may be used to stimulate hair growth, though results vary.
  • Lifestyle adjustments: Ensuring adequate nutrition and reducing stress may support hair health.
  • Consultation with a dermatologist: For persistent cases, specialized care may be recommended.

Prognosis and Follow-Up

Prognosis is generally favorable if the causative drug is discontinued early. Hair regrowth may occur over several months, but complete recovery depends on the extent of follicle damage. Follow-up with a healthcare provider is recommended to monitor progress and address any underlying conditions.

Complications

  • Persistent hair loss if the causative drug cannot be discontinued
  • Psychological distress due to changes in appearance
  • Potential progression to irreversible hair loss in severe cases

Lifestyle & Prevention

  • Avoid unnecessary use of medications known to cause hair loss.
  • Discuss alternative treatments with a healthcare provider if hair loss is a concern.
  • Maintain a balanced diet rich in vitamins and minerals to support hair health.
  • Practice gentle hair care to minimize additional stress on follicles.

When to Seek Professional Help

Seek medical attention if hair loss is sudden, extensive, or accompanied by other symptoms (e.g., scalp pain, rash). A healthcare provider can help identify the cause and recommend appropriate management.

Tips for Medical Coders

When coding for drug-induced androgenic alopecia (ICD10CM: L64.0), ensure documentation clearly links the hair loss to a specific medication. Include details about the drug name, duration of use, and any attempts to discontinue or substitute the medication. Accurate coding requires confirmation that the alopecia is directly attributable to drug exposure rather than other causes.

Medical Policies and Guidelines

Related policies from health plans

Serum iron Testing
CG-LAB-21 Serum Iron Testing
Book a walkthrough

L64.0 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.